Geriatric Telemanagement of HEALTH Conditions in Nursing Home Residents Recently Discharged From the Hospital- GET HEALTH-I (GET-HEALTH-I)

September 1, 2025 updated by: Istituto Nazionale di Ricovero e Cura per Anziani

Definition and Testing of a New Model of Clinical Governance Based on the Integration of Tools Such as Health Technology Assessment, Clinical Practice Guidelines, Clinical Pathways, and Healthcare Performance Measurement for Planning, Implementation and Management of Healthcare Interventions in Different Settings - INTEGRATE-HEALTH-GOV - Geriatric Telemanagement of HEALTH Conditions in Nursing Home Residents Recently Discharged From the Hospital GET HEALTH-I

Get-HEALTH-I study is a retrospective prospective interventional study to evaluate the impact of a geriatric telemanagement program on cost-effectiveness and clinical outcomes in nursing home residents post-hospital discharge.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The GET HEALTH-I is a before and after study, consisting of both a retrospective and prospective component. The retrospective component of the study includes nursing home residents in the Marche region (Italy) who are readmitted to the nursing home after a hospital discharge, before the implementation of geriatric telemanagement. The prospective component, includes nursing home residents who are readmitted to the nursing home after a hospital discharge and are managed with the geriatric telemedicine intervention in addition to usual care. The primary objective of the study is to develop a geriatric co-management governance model using telemedicine for elderly patients with multimorbidity discharged from the hospital to nursing homes.The model will integrate geriatric specialists with nursing home staff and general practitioners.

A secondary objective of the study is to measure the performance of the model in terms of effectiveness and cost-effectiveness. In particular, an evaluation will be conducted on the effects of implementing the geriatric telemanagement governance model on the risk of hospitalization, geriatric syndromes (falls, delirium, pressure ulcers), number of medications, and inappropriate prescriptions. Adherence to the intervention by GPs and nursing home staff, satisfaction and perception of utility, costs, healthcare resource utilization, and cost-effectiveness will be evaluated.

Study Type

Interventional

Enrollment (Estimated)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Nursing home residents discharged from the hospital within one week of admission to the nursing home

Exclusion Criteria:

  • Residents admitted for a short-term stay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nursing home residents
A geriatric comprehensive assessment (CGA) will be conducted in nursing home residents using the data collection form by a multidisciplinary team led by the geriatrician, together with the family physician and the nursing home staff. The geriatrician will review the diagnoses, treatments, and results of the CGA. The patient will be interviewed and examined by the team, and then a multidisciplinary conference will be organized.
Other: Geriatric telemanagement
The geriatrician will coordinate, through a telemedicine consultation, a team consisting of the general practitioner and the nursing home staff. The geriatrician will review the diagnoses, treatments, and results of the comprehensive geriatric assessment performed by the nursing home staff. Subsequently, the entire team will conduct a multidisciplinary conference.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
reduction in hospitalization rate
Time Frame: After 6 months from baseline
A minimum 15% reduction in the hospitalization rate will define the efficacy of the geriatric telemedicine consultation intervention
After 6 months from baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Istituto Nazionale di Ricovero e Cura per Anziani

Collaborators

Ministry of Health, Italy

Investigators

  • Principal Investigator: Antonio Cherubini, MD, IRCCS INRCA, Ancona, Italy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 4, 2024

Primary Completion (Estimated)

March 31, 2026

Study Completion (Estimated)

March 31, 2026

Study Registration Dates

First Submitted

March 18, 2025

First Submitted That Met QC Criteria

March 18, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Estimated)

September 8, 2025

Last Update Submitted That Met QC Criteria

September 1, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • INRCA_001_2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Older Hospitalized Patients

Clinical Trials on Geriatric telemanagement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe